Gene Expression Regulation, Neoplastic

Displaying 1 - 7 of 7CSV
Lee, M. K., Azizgolshani, N., Zhang, Z., Perreard, L., Kolling, F. W., Nguyen, L. N., Zanazzi, G. J., Salas, L. A., & Christensen, B. C. (2024). Associations in cell type-specific hydroxymethylation and transcriptional alterations of pediatric central nervous system tumors. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-47943-9
Publication Date
Lee, M. K., Azizgolshani, N., Shapiro, J. A., Nguyen, L. N., Kolling, F. W., Zanazzi, G. J., Frost, H. R., & Christensen, B. C. (2024). Identifying tumor type and cell type-specific gene expression alterations in pediatric central nervous system tumors. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-47712-8
Publication Date
Yan, H., Yu, C.-C., Fine, S. A., Youssof, A. L., Yang, Y.-R., Yan, J., Karg, D. C., Cheung, E. C., Friedman, R. A., Ying, H., Chen, E. I., Luo, J., Miao, Y., Qiu, W., & Su, G. H. (2021). Loss of the wild-type KRAS allele promotes pancreatic cancer progression through functional activation of YAP1. Oncogene, 40(50), 6759–6771. https://doi.org/10.1038/s41388-021-02040-9
Publication Date
Liu, Y., Wu, Z., Zhou, J., Ramadurai, D. K. A., Mortenson, K. L., Aguilera-Jimenez, E., Yan, Y., Yang, X., Taylor, A. M., Varley, K. E., Gertz, J., Choi, P. S., Cherniack, A. D., Chen, X., Bass, A. J., Bailey, S. D., & Zhang, X. (2021). A predominant enhancer co-amplified with the SOX2 oncogene is necessary and sufficient for its expression in squamous cancer. Nature Communications, 12(1). https://doi.org/10.1038/s41467-021-27055-4
Publication Date
Park, S., Rong, L., Owczarek, T. B., Bernardo, M. D., Shoulson, R. L., Chua, C.-W., Kim, J. Y., Lankarani, A., Chakrapani, P., Syed, T., McKiernan, J. M., Solit, D. B., Shen, M. M., Al-Ahmadie, H. A., & Abate-Shen, C. (2021). Novel Mouse Models of Bladder Cancer Identify a Prognostic Signature Associated with Risk of Disease Progression. Cancer Research, 81(20), 5161–5175. https://doi.org/10.1158/0008-5472.can-21-1254
Publication Date
Geethadevi, A., Nair, A., Parashar, D., Ku, Z., Xiong, W., Deng, H., Li, Y., George, J., McAllister, D. M., Sun, Y., Kadamberi, I. P., Gupta, P., Dwinell, M. B., Bradley, W. H., Rader, J. S., Rui, H., Schwabe, R. F., Zhang, N., Pradeep, S., … Chaluvally-Raghavan, P. (2021). Oncostatin M Receptor–Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth. Cancer Research, 81(20), 5336–5352. https://doi.org/10.1158/0008-5472.can-21-0483
Publication Date